Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Greenwich Lifesciences Inc (GLSI)

Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Greenwich Lifesciences Inc 3992 BLUEBONNET DR BUILDING 14 STAFFORD TX 77477 USA

www.greenwichlifesciences.com P: 832-819-3232

Description:

Greenwich LifeSciences Inc. is a clinical stage biopharmaceutical company focuses on the development of cancer immunotherapies for breast cancer and other human epidermal growth factor. The company's product candidate includes GP2, which is in clinical stage. Greenwich LifeSciences Inc.is based in Stafford, Texas.

Key Statistics

Overview:

Market Capitalization, $K 163,422
Enterprise Value, $K 156,432
Shares Outstanding, K 12,878
Annual Sales, $ 0 K
Annual Net Income, $ -7,830 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,750 K
EBIT, $ -9,330 K
EBITDA, $ -9,330 K
60-Month Beta 1.37
% of Insider Shareholders 52.86%
% of Institutional Shareholders 4.16%
Float, K 6,071
% Float 47.14%
Short Volume Ratio 0.47

Growth:

1-Year Return 14.88%
3-Year Return -66.25%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 04/15/24
Latest Earnings Date 05/27/24
Earnings Per Share ttm -0.70
EPS Growth vs. Prev Qtr -10.53%
EPS Growth vs. Prev Year 4.55%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GLSI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -93.88%
Return-on-Assets % -91.16%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 24.72
Book Value/Share 0.52
Interest Coverage -4.45
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar